# Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression

> **NCT05045378** · PHASE4 · COMPLETED · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 12 (actual)

## Conditions studied

- Treatment-resistant Depression
- Major Depressive Disorder

## Interventions

- **DRUG:** Midazolam (active placebo)
- **DRUG:** Ketamine and Midazolam (active placebo)
- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT05045378
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-15
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05045378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05045378, "Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05045378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*